2019年ADA糖尿病医学诊疗标准:血糖治疗的药物方法
美国糖尿病协会(ADA)专业实践委员会多学科专家小组更新了2019年糖尿病医学诊疗标准,其中第9部分聚焦血糖治疗的药物方法,提供当前临床实践推荐、治疗目标和质量评估工具。
要点
- ADA标准每年更新,提供糖尿病诊疗推荐与质量评估工具。
- 第9部分专门阐述血糖治疗的药物方法。
- 推荐基于证据分级系统,详见标准介绍。
核心结论
- ADA标准包含当前临床实践推荐,提供糖尿病诊疗组件、一般治疗目标与指南及质量评估工具。
研究设计与样本
- ADA专业实践委员会(多学科专家委员会)负责每年或必要时更频繁更新标准。
临床怎么用
- 临床医生可依据该标准进行血糖治疗的药物选择与质量评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019. PMID: 30559235. doi:10.2337/dc19-S009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。